• Humanized Mice Advance CES Prodrug PK: HD56 In Vivo-In Vitro

  2026-05-08

  This study establishes humanized mice as superior models for predicting the in vivo pharmacokinetics of carboxylate ester prodrugs such as HD56, which targets FK506 binding proteins. The findings provide a validated framework for addressing species differences in prodrug metabolism, informing future translational research and therapeutic development.

• Neuroligin 1 Proteolysis Regulates Social Memory Maintenance

  2026-05-07

  Liu et al. (2025) demonstrate that social interaction-induced proteolytic processing of neuroligin 1 in the ventral hippocampus is critical for sustaining short-term social memory. This mechanistic insight bridges synaptic remodeling with memory maintenance, offering new directions for neuropsychiatric research.

• DMXAA (Vadimezan): Vascular Disrupting Agent for Cancer Rese

  2026-05-07

  DMXAA (Vadimezan) is a vascular disrupting agent and multi-kinase inhibitor with established efficacy in disrupting tumor vasculature and inducing apoptosis in endothelial cells. It selectively inhibits DT-diaphorase and VEGFR2 signaling, making it a valuable tool for cancer biology research. APExBIO provides validated DMXAA (A8233) for reproducible preclinical workflows.

• Pam3CSK4 as a TLR1/2 Agonist: Applied Workflows & Innovation

  2026-05-06

  Pam3CSK4, a synthetic TLR1/2 agonist from APExBIO, empowers researchers to precisely activate innate immune responses and model inflammatory diseases with high reproducibility. This article delivers protocol enhancements, troubleshooting insights, and cross-disciplinary innovation, maximizing the impact of Pam3CSK4 in translational immunology.

• Isradipine (Dynacirc): Precision Modulation of L-Type Calciu

  2026-05-06

  Isradipine (Dynacirc) is a gold-standard dihydropyridine calcium channel blocker, enabling robust and selective inhibition of L-type channels in both cardiovascular and neuroprotective research. This article delivers actionable protocols, troubleshooting tactics, and comparative workflow insights grounded in recent literature, maximizing the reliability and versatility of Isradipine sourced from APExBIO.

• Reserpine (N1867): Technical Use and Protocol Optimization G

  2026-05-05

  Reserpine (N1867) is a high-purity, bioactive compound used for controlled neurotransmitter depletion and related neuropharmacology research. It is not suitable for diagnostic or medical applications and should be implemented in workflows that can accommodate its solubility and stability requirements.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-05-05

  This study reveals that certain kinase inhibitors can both block kinase activity and promote dephosphorylation of their targets by stabilizing unique activation loop conformations. These findings provide a mechanistic basis for designing more potent and specific inhibitors, with broad implications for kinase-driven disease research.

• LLY-507: A Potent SMYD2 Inhibitor for Cancer and Fibrosis Re

  2026-05-04

  LLY507, a highly selective SMYD2 inhibitor from APExBIO, empowers researchers to dissect epigenetic mechanisms in cancer and renal fibrosis with precision. This article details evidence-backed workflows, advanced applications, and troubleshooting insights to maximize LLY507’s impact in translational and preclinical studies.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-05-04

  This study uncovers that certain kinase inhibitors not only block p38α MAPK activity but also promote its dephosphorylation by stabilizing a phosphatase-accessible conformation. These insights expand mechanistic understanding of kinase regulation and offer new avenues to achieve specificity in inflammatory and cytokine inhibition research.

• GANT61 in Tumor Immune Evasion: Beyond Canonical GLI Inhibit

  2026-05-03

  Explore how GANT61, a potent GLI inhibitor, is redefining cancer research by targeting tumor immune evasion mechanisms. This in-depth analysis reveals new insights tying Hedgehog pathway blockade to immunotherapy resistance, setting this article apart from existing workflow guides.

• Applied Use of BPN-19186 in sEH-Nrf2 Signaling Pathway Modul

  2026-05-02

  BPN-19186 ((S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea) enables robust, reproducible modulation of the sEH-Nrf2 axis in biochemical and disease-model assays. Its high purity and solubility profile empower advanced signaling pathway and enzyme inhibition studies, with protocol refinements that streamline troubleshooting and maximize assay fidelity.

• Multiomics Dissection of Crossbreeding Effects in Xingguo Ge

  2026-05-02

  This study employs integrated transcriptomic and metabolomic analyses to reveal how crossbreeding and sex influence growth, slaughter performance, and meat quality in Xingguo gray geese. The findings highlight regulatory networks affecting muscle development and lipid metabolism, providing a molecular basis for improving goose production traits.

• A Drug-Sensitized Yeast Platform for mTOR Inhibitor Discover

  2026-05-01

  This study introduces a highly sensitive yeast-based screening system for identifying mTOR inhibitors, enhancing detection by over 200-fold compared to wild-type strains. The platform enables rapid, cost-effective discovery of TOR pathway modulators and clarifies compound selectivity, with implications for geroprotective and anti-cancer research.

• Paclitaxel (Taxol) in Cancer Research: Protocols & Innovatio

  2026-04-30

  Paclitaxel (Taxol) remains the gold standard for modeling cell cycle arrest and apoptosis in oncology research, enabling robust preclinical workflows. Here, we detail cutting-edge experimental strategies, protocol enhancements, and troubleshooting guidance to maximize its application in breast and ovarian cancer models.

• Dihydroethidium (DHE): Next-Gen Redox Assays via Nrf2-GPX4 A

  2026-04-30

  Explore how Dihydroethidium (DHE) empowers advanced intracellular reactive oxygen species measurement by leveraging insights from the Nrf2/GPX4 antioxidant axis. This article delivers a unique, application-focused guide for researchers in oxidative stress and ferroptosis.

408 records 16/28 page Previous Next First page 上5页 1617181920 下5页 Last page